Gyroscope Capital Management Group’s HCA Healthcare HCA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-7,939
Closed -$1.91M 176
2022
Q4
$1.91M Buy
7,939
+571
+8% +$128K 0.58% 40
2022
Q3
$1.35M Sell
7,368
-124
-2% -$24.7K 0.52% 50
2022
Q2
$1.26M Buy
7,492
+1,127
+18% +$242K 0.43% 54
2022
Q1
$1.59M Buy
6,365
+396
+7% +$99.4K 0.55% 43
2021
Q4
$1.53M Sell
5,969
-71
-1% -$17.4K 0.54% 43
2021
Q3
$1.47M Sell
6,040
-1,270
-17% -$310K 0.55% 41
2021
Q2
$1.51M Sell
7,310
-108
-1% -$22K 0.53% 40
2021
Q1
$1.4M Buy
7,418
+215
+3% +$37.9K 0.56% 39
2020
Q4
$1.19M Sell
7,203
-694
-9% -$101K 0.51% 46
2020
Q3
$985K Sell
7,897
-188
-2% -$23.3K 0.45% 47
2020
Q2
$785K Buy
+8,085
New +$841K 0.36% 53

Other funds holding HCA

Gyroscope Capital Management Group's HCA Position: Q1 2023 in Review

Gyroscope Capital Management Group sold out of HCA Healthcare (HCA) in Q1 2023, closing a stake of 7,939 shares — an estimated $1.91M sold.

Gyroscope Capital Management Group first reported a position in HCA in Q2 2020 and held it in 11 quarters. The position peaked at $1.91M in Q4 2022. 970 funds tracked by Wall St. Rank hold HCA as of Q1 2023.

  • Gyroscope Capital Management Group reported no remaining HCA Healthcare position as of Q1 2023 after selling out during the quarter.
  • Gyroscope Capital Management Group sold 7,939 HCA Healthcare shares in Q1 2023, an estimated $1.91M.
  • Gyroscope Capital Management Group first reported a position in HCA Healthcare in Q2 2020 and held it in 11 quarters.
  • Gyroscope Capital Management Group's HCA Healthcare position peaked at $1.91M in Q4 2022.
  • 970 funds tracked by Wall St. Rank held HCA Healthcare as of Q1 2023.

Based on Gyroscope Capital Management Group's 13F filing for Q1 2023, filed 3 May 2023.